Regulation of the NK-1 receptor gene expression in human macrophage cells via an NF-κB site on its promoter

  1. Simos Simeonidis,
  2. Ignazio Castagliuolo,
  3. Amy Pan,
  4. Jennifer Liu,
  5. Chi-Chi Wang,
  6. Andreas Mykoniatis,
  7. Asia Pasha,
  8. Leyla Valenick,
  9. Stavros Sougioultzis,
  10. Dezheng Zhao, and
  11. Charalabos Pothoulakis*
  1. Division of Gastroenterology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215
  1. Communicated by Susan E. Leeman, Boston University School of Medicine, Boston, MA (received for review November 1, 2002)

Abstract

We report here that human monocytic/macrophage THP-1 cells express the neurokinin 1 receptor (NK-1R), and that exposure of these cells to the proinflammatory cytokine IL-1β increased the expression of the NK-1R gene at the mRNA and protein levels. Because IL-1β function involves nuclear factor κB (NF-κB) activation, these data suggest that this increase in the expression of the NK-1R gene is mediated by the NF-κB transcription factor. An earlier report noted that the promoter region of the human NK-1R gene contains a putative binding site for NF-κB [Takahashi, K., Tanaka, A., Hara, M. & Nakanishi, S. (1992) Eur. J. Biochem. 204, 1025–1033]. Here we demonstrate that this is indeed a functional NF-κB-binding site, and that NF-κB is responsible for regulating the expression of the NK-1R gene by binding to the promoter region of the NK-1R gene. To further substantiate that the observed NF-κB-dependent IL-1β induction of the human NK-1R gene is regulated via a transcriptional event through this NF-κB site on the NK-1R gene promoter, we transfected THP-1 cells with a luciferase promoter-reporter construct containing the 5′ promoter region of the human NK-1R gene. Exposure of these cells to IL-1β or overexpression of NF-κB cDNAs resulted in a significant increase in the amount of luciferase activity that was diminished greatly in cells transfected with IκBα, the NF-κB inhibitor. These results directly implicate NF-κB in the regulation of the NK-1R gene and provide a molecular mechanism for the increase in expression of the NK-1R gene in responsive cells.

Footnotes

  • * To whom correspondence should be addressed at: Beth Israel Deaconess Medical Center, Division of Gastroenterology, Dana 601, 330 Brookline Avenue, Boston, MA 02215. E-mail: cpothoul{at}caregroup.harvard.edu.

  • Abbreviations:
    NK-1,
    neurokinin 1;
    NK-1R,
    NK-1 receptor;
    IκB,
    inhibitor of κB;
    TNFα,
    tumor necrosis factor α;
    rh,
    recombinant human;
    RT,
    reverse transcription;
    IκBα,
    inhibitor of NF-κB;
    EMSA,
    electrophoretic mobility-shift assay
« Previous | Next Article »Table of Contents